BRITTANY DROZDO: Open Payments
NPI 1013402148 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 8 companies in 2025. Trend: 2023 $104 · 2024 $44 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $75 |
| GENZYME CORPORATION | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| UCB, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, Bimzelx, OTEZLA, SPEVIGO, TREMFYA, CIBINQO.
Industry payments across VA — which companies pay providers there.
